Investing
Proceeds from Sale of Seagen Inc. Common Stock
Chubb Proceeds from Sale of Seagen Inc. Common Stock increased by 47.3% to $878.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 37.8%, from $637.00M to $878.00M. Over 4 years (FY 2021 to FY 2025), Proceeds from Sale of Seagen Inc. Common Stock shows an upward trend with a 28.9% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ1 2019
Last reportedQ1 2026Apr 28, 2026
Metric ID:
mrk_proceeds_from_sale_of_seagen_stockHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $263.00M | $136.00M | $268.00M | $1.11B | $1.34B | $2.01B | $162.00M | $43.00M | $38.00M | $450.00M | $553.00M | $520.00M | $893.00M | $543.00M | $1.04B | $637.00M | $773.00M | $801.00M | $596.00M | $878.00M |
| QoQ Change | — | -48.3% | +97.1% | +314.2% | +20.3% | +50.4% | -91.9% | -73.5% | -11.6% | >999% | +22.9% | -6.0% | +71.7% | -39.2% | +91.5% | -38.8% | +21.4% | +3.6% | -25.6% | +47.3% |
| YoY Change | — | — | — | — | +407.6% | >999% | -39.6% | -96.1% | -97.2% | -77.6% | +241.4% | >999% | >999% | +20.7% | +88.1% | +22.5% | -13.4% | +47.5% | -42.7% | +37.8% |
Range$38.00M – $2.01B
CAGR+28.9%
Avg YoY Growth+327.2%
Median YoY Growth+30.2%
Proceeds from Sale of Seagen Inc. Common Stock at Other Companies
Frequently Asked Questions
- What is Chubb's proceeds from sale of seagen inc. common stock?
- Chubb (CB) reported proceeds from sale of seagen inc. common stock of $878.00M in Q1 2026.
- How has Chubb's proceeds from sale of seagen inc. common stock changed year-over-year?
- Chubb's proceeds from sale of seagen inc. common stock increased by 37.8% year-over-year, from $637.00M to $878.00M.
- What is the long-term trend for Chubb's proceeds from sale of seagen inc. common stock?
- Over 4 years (2021 to 2025), Chubb's proceeds from sale of seagen inc. common stock has grown at a 28.9% compound annual growth rate (CAGR), from $1.02B to $2.81B.